DAWN (Drug-Assisted Weight Normalization): Normalizing the Pursuit for Health

Authors

  • Dr Sanjay Kalra Treasurer, International Society of Endocrinology (ISE); Vice President, South Asian Obesity Forum (SOF); Bharti Hospital, Karnal, Haryana, India
  • Dr Suneet Kumar Verma Dept. of Medicine, Alchemist Hospital, Panchkula, Haryana; Sparsh Clinic, Panchkula, Haryana, India
  • Dr Nitin Kapoor Dept. of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu, India; Noncommunicable Disease Unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

DOI:

https://doi.org/10.59793/gpygaj43

Keywords:

Antiobesity medications,, GLP-1 receptor agonists,, incretin therapy,, medical management of obesity

Abstract

Obesity is accepted as a disease by professional organizations across the world. The rise in its prevalence has been matched
by enhanced understanding of its causation, clinical trajectory as well as complications. Endocrinologists are now able to
treat obesity with a variety of interventions, including behavioral, dietary, oral, injectable, invasive, and surgical therapies.
In this manuscript, we describe highly effective antiobesity medications available for weight loss.

Downloads

Published

2025-06-16

Issue

Vol. 36 No. 1 (2025)

Section

Viewpoint

How to Cite

DAWN (Drug-Assisted Weight Normalization): Normalizing the Pursuit for Health. (2025). Indian Journal Of Clinical Practice, 36(1), 1-2. https://doi.org/10.59793/gpygaj43

Similar Articles

1-10 of 362

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 > >>